Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 95

1.

Granular cell tumors of the tracheobronchial tree.

van der Maten J, Blaauwgeers JL, Sutedja TG, Kwa HB, Postmus PE, Wagenaar SS.

J Thorac Cardiovasc Surg. 2003 Sep;126(3):740-3.

2.

Occurrence of esophageal granular cell tumors in The Netherlands between 1988 and 1994.

Voskuil JH, van Dijk MM, Wagenaar SS, van Vliet AC, Timmer R, van Hees PA.

Dig Dis Sci. 2001 Aug;46(8):1610-4.

PMID:
11508657
3.

Bronchoalveolar lavage fluid cytology in patients with Pneumocystis carinii pneumonia.

Jacobs JA, Dieleman MM, Cornelissen EI, Groen EA, Wagenaar SS, Drent M.

Acta Cytol. 2001 May-Jun;45(3):317-26.

PMID:
11393061
4.

Cytocentrifugation conditions affecting the differential cell count in bronchoalveolar lavage fluid.

De Brauwer EI, Jacobs JA, Nieman F, Bruggeman CA, Wagenaar SS, Drent M.

Anal Quant Cytol Histol. 2000 Oct;22(5):416-22.

PMID:
11064819
5.

Differential cell analysis of cytocentrifuged bronchoalveolar fluid samples affected by the area counted.

De Brauwer EI, Drent M, Mulder PG, Bruggeman CA, Wagenaar SS, Jacobs JA.

Anal Quant Cytol Histol. 2000 Apr;22(2):143-9.

PMID:
10800616
6.

Sarcoidlike lung granulomatosis induced by glass fibre exposure.

Drent M, Kessels BL, Bomans PH, Wagenaar SS, Henderson RF.

Sarcoidosis Vasc Diffuse Lung Dis. 2000 Mar;17(1):86-7. No abstract available.

PMID:
10746267
7.

Relationship between pernicious anaemia and gastric neuroendocrine cell disorders.

Spoelstra-de Man AM, Wagenaar SS, van der Sluys Veer A, Brouwer CB.

Neth J Med. 2000 Feb;56(2):56-62. Review.

PMID:
10710942
8.

Detection of non-infectious conditions mimicking pneumonia in the intensive care setting: usefulness of bronchoalveolar fluid cytology.

Jacobs JA, De Brauwer EI, Ramsay G, Cobben NA, Wagenaar SS, van der Ven AJ, Bruggeman CA, Drent M.

Respir Med. 1999 Aug;93(8):571-8.

9.

[Nonspecific symptoms due to gastrointestinal stromal tumors].

Blaauwgeers JL, Hoitsma HF, Geraedts AA, Wagenaar SS.

Ned Tijdschr Geneeskd. 1999 Jun 12;143(24):1241-5. Dutch.

PMID:
10396333
10.

[New WHO-classification of lung and pleural tumors].

Wagenaar SS.

Ned Tijdschr Geneeskd. 1999 May 8;143(19):984-90. Dutch.

PMID:
10368718
11.

[Diagnostic examination for causes of exudative pleurisy].

Schouwink JH, Toben FM, Wagenaar SS.

Ned Tijdschr Geneeskd. 1998 Nov 21;142(47):2553-6. Dutch.

PMID:
10028349
12.

Diagnosis of Pneumocystis carinii pneumonia in HIV-positive patients. Bronchoalveolar lavage vs. bronchial brushing.

Djamin RS, Drent M, Schreurs AJ, Groen EA, Wagenaar SS.

Acta Cytol. 1998 Jul-Aug;42(4):933-8.

PMID:
9684580
13.

Pulmonary infiltration associated with myelodysplasia.

Drent M, Peters FP, Jacobs JA, Maassen van de Brink KI, Wagenaar SS, Wouters EF.

Ann Oncol. 1997 Sep;8(9):905-9.

PMID:
9358943
14.

A comparison of NSP-reticulons with conventional neuroendocrine markers in immunophenotyping of lung cancers.

Senden NH, Timmer ED, de Bruïne A, Wagenaar SS, Van de Velde HJ, Roebroek AJ, Van de Ven WJ, Broers JL, Ramaekers FC.

J Pathol. 1997 May;182(1):13-21.

PMID:
9227337
15.

Intravenous leiomyomatosis complicated by Budd-Chiari syndrome.

Kuenen BC, Slee PH, Seldenrijk CA, Wagenaar SS.

Postgrad Med J. 1996 Nov;72(853):686-8. No abstract available.

16.

Serum LDH: a marker of disease activity and its response to therapy in idiopathic pulmonary fibrosis.

van Krugten M, Cobben NA, Lamers RJ, van Dieijen-Visser MP, Wagenaar SS, Wouters EF, Drent M.

Neth J Med. 1996 Jun;48(6):220-3.

PMID:
8710042
17.

Cytomegalovirus induces interstitial lung disease in allogeneic bone marrow transplant recipient rats independent of acute graft-versus-host response.

Stals FS, Steinhoff G, Wagenaar SS, van Breda Vriesman JP, Haverich A, Dormans P, Moeller F, Bruggeman CA.

Lab Invest. 1996 Feb;74(2):343-52.

PMID:
8780154
18.

Combinations of ganciclovir and antibody for experimental CMV infections.

Stals FS, Wagenaar SS, Kloover JS, Vanagt WY, Bruggeman CA.

Antiviral Res. 1996 Jan;29(1):61-4.

PMID:
8721547
19.

Relationship between cells obtained by bronchoalveolar lavage and survival in idiopathic pulmonary fibrosis.

Boomars KA, Wagenaar SS, Mulder PG, van Velzen-Blad H, van den Bosch JM.

Thorax. 1995 Oct;50(10):1087-92.

20.

Invasive aspergillosis after bilateral lung transplantation in cystic fibrosis.

Drent M, van Rens MT, Wagenaar SS, de Jongh BM, van Velzen-Blad H, van den Bosch JM.

Respir Med. 1995 Jul;89(6):449-51. No abstract available.

21.

The choriocarcinoma syndrome: an emergency.

Voskuil JH, Slee PH, Wagenaar SS.

Neth J Med. 1995 May;46(5):232-5.

PMID:
7783824
22.

Evaluation of proliferation parameters in in vivo bromodeoxyuridine labelled lung cancers.

Tinnemans MM, Lenders MH, ten Velde GP, Wagenaar SS, Blijham GH, Ramaekers FC, Schutte B.

Virchows Arch. 1995;427(3):295-301.

PMID:
7496600
23.

Ten years after the WHO classification for lung cancer: where are we?

Wagenaar SS, Tazelaar HD.

Lung Cancer. 1994 Nov;11 Suppl 3:S39-43. No abstract available.

PMID:
7704511
24.

Primary sarcoma of the lung: a clinical study with long-term follow-up.

Janssen JP, Mulder JJ, Wagenaar SS, Elbers HR, van den Bosch JM.

Ann Thorac Surg. 1994 Oct;58(4):1151-5.

PMID:
7944769
26.

Bronchoalveolar lavage fluid profiles in sarcoidosis, tuberculosis, and non-Hodgkin's and Hodgkin's disease. An evaluation of differences.

Drent M, Wagenaar SS, Mulder PH, van Velzen-Blad H, Diamant M, van den Bosch JM.

Chest. 1994 Feb;105(2):514-9.

PMID:
7905815
27.

Expression and modulation of adhesion molecules on human bronchial epithelial cells.

Bloemen PG, van den Tweel MC, Henricks PA, Engels F, Wagenaar SS, Rutten AA, Nijkamp FP.

Am J Respir Cell Mol Biol. 1993 Dec;9(6):586-93.

PMID:
7504927
28.

Bronchoalveolar lavage in extrinsic allergic alveolitis: effect of time elapsed since antigen exposure.

Drent M, van Velzen-Blad H, Diamant M, Wagenaar SS, Hoogsteden HC, van den Bosch JM.

Eur Respir J. 1993 Oct;6(9):1276-81.

PMID:
8287943
29.

Nuclear A-type lamins are differentially expressed in human lung cancer subtypes.

Broers JL, Raymond Y, Rot MK, Kuijpers H, Wagenaar SS, Ramaekers FC.

Am J Pathol. 1993 Jul;143(1):211-20.

30.

Differential diagnostic value of plasma cells in bronchoalveolar lavage fluid.

Drent M, van Velzen-Blad H, Diamant M, Wagenaar SS, Donckerwolck-Bogaert M, van den Bosch JM.

Chest. 1993 Jun;103(6):1720-4.

PMID:
8404090
31.

Differences in BAL fluid variables in interstitial lung diseases evaluated by discriminant analysis.

Drent M, Mulder PG, Wagenaar SS, Hoogsteden HC, van Velzen-Blad H, van den Bosch JM.

Eur Respir J. 1993 Jun;6(6):803-10.

PMID:
8339798
32.

Mediastinal lymph node enlargement as a result of mitral valve stenosis.

Drent M, Gelissen JP, Ascoop CA, Wagenaar SS, van den Bosch JM.

Chest. 1992 Oct;102(4):1269-71.

PMID:
1395780
33.

Laminin and type VII collagen distribution in different types of human lung carcinoma: correlation with expression of keratins 14, 16, 17 and 18.

Wetzels RH, Schaafsma HE, Leigh IM, Lane EB, Troyanovsky SM, Wagenaar SS, Vooijs GP, Ramaekers FC.

Histopathology. 1992 Apr;20(4):295-303.

PMID:
1374358
34.

Monoclonal antibody MON-114: detection of a marker for neuroendocrine differentiation in human lung cancer.

van Duijnhoven HL, Moors EH, Groeneveld A, Timmer ED, de Leij LF, Wagenaar SS, Polak JM, van de Ven WJ.

Cancer Lett. 1992 Mar 31;63(1):61-6.

PMID:
1313334
35.

Neural cell adhesion molecule expression, neuroendocrine differentiation and prognosis in lung carcinoma.

Kibbelaar RE, Moolenaar KE, Michalides RJ, Van Bodegom PC, Vanderschueren RG, Wagenaar SS, Dingemans KP, Bitter-Suermann D, Dalesio O, Van Zandwijk N, et al.

Eur J Cancer. 1991;27(4):431-5.

PMID:
1851619
36.

Ultrastructural heterogeneity of lung carcinomas: representativity of samples for electron microscopy in tumor classification.

Mooi WJ, Dingemans KP, Wagenaar SS, Hart AA, Wagenvoort CA.

Hum Pathol. 1990 Dec;21(12):1227-34.

PMID:
2249836
37.

[localized fibrous tumors of the pleura].

Janssen JP, Wagenaar SS, van den Bosch JM, Planteydt HT.

Ned Tijdschr Geneeskd. 1990 Nov 10;134(45):2185-9. Dutch.

PMID:
2247187
38.

K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung.

Slebos RJ, Kibbelaar RE, Dalesio O, Kooistra A, Stam J, Meijer CJ, Wagenaar SS, Vanderschueren RG, van Zandwijk N, Mooi WJ, et al.

N Engl J Med. 1990 Aug 30;323(9):561-5.

39.

[Endobronchial hamartoma; a benign mesenchymal tumor].

Peels JO, van den Bosch JM, Wagenaar SS.

Ned Tijdschr Geneeskd. 1990 Mar 10;134(10):481-3. Dutch.

PMID:
2314488
40.

Basement membranes in bronchogenic squamous cell carcinoma: an immunohistochemical and ultrastructural study.

Havenith MG, Dingemans KP, Cleutjens JP, Wagenaar SS, Bosman FT.

Ultrastruct Pathol. 1990 Jan-Feb;14(1):51-63.

PMID:
2296803
41.

Second primary lung cancer: importance of long term follow up.

van Bodegom PC, Wagenaar SS, Corrin B, Baak JP, Berkel J, Vanderschueren RG.

Thorax. 1989 Oct;44(10):788-93.

43.

Differential expression of the gene encoding the novel pituitary polypeptide 7B2 in human lung cancer cells.

Roebroek AJ, Martens GJ, Duits AJ, Schalken JA, van Bokhoven A, Wagenaar SS, Van de Ven WJ.

Cancer Res. 1989 Aug 1;49(15):4154-8.

44.

Expression of intermediate filament proteins in fetal and adult human lung tissues.

Broers JL, de Leij L, Rot MK, ter Haar A, Lane EB, Leigh IM, Wagenaar SS, Vooijs GP, Ramaekers FC.

Differentiation. 1989 May;40(2):119-28.

PMID:
2474472
45.

Quantitative pathologic analysis of first and second primary cancers in double tumors of the lung.

van Bodegom PC, Baak JP, van Galen C, Vanderschueren RG, Wagenaar SS.

Anal Quant Cytol Histol. 1989 Feb;11(1):43-7.

PMID:
2719795
46.

Pulmonary capillary haemangiomatosis diagnosed during life.

Wagenaar SS, Mulder JJ, Wagenvoort CA, van den Bosch JM.

Histopathology. 1989 Feb;14(2):212-4. No abstract available.

PMID:
2707754
47.

The percentage of aneuploid cells is significantly correlated with survival in accurately staged patients with stage 1 resected squamous cell lung cancer and long-term follow up.

van Bodegom PC, Baak JP, Stroet-van Galen C, Schipper NW, Wisse-Brekelmans EC, Vanderschueren RG, Wagenaar SS.

Cancer. 1989 Jan 1;63(1):143-7.

PMID:
2910413
48.

Cellular protoonocogenes are infrequently amplified in untreated non-small cell lung cancer.

Slebos RJ, Evers SG, Wagenaar SS, Rodenhuis S.

Br J Cancer. 1989 Jan;59(1):76-80.

49.

Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung.

Rodenhuis S, Slebos RJ, Boot AJ, Evers SG, Mooi WJ, Wagenaar SS, van Bodegom PC, Bos JL.

Cancer Res. 1988 Oct 15;48(20):5738-41.

Supplemental Content

Loading ...
Support Center